Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-20T08:33:14.090Z Has data issue: false hasContentIssue false
  • English
  • Français

WCA Recommendations for the Long-Term Treatment of Posttraumatic Stress Disorder

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein ,
Borwin Bandelow ,
Eric Hollander ,
David J. Nutt ,
Ahmed Okasha ,
Mark H. Pollack ,
Richard P. Swinson  and
Joseph Zohar
Get access Rights & Permissions [Opens in a new window]

Abstract

Posttraumatic stress disorder (PTSD) is a common and disabling condition. In addition to combat-related PTSD, the disorder occurs in civilians exposed to severe traumatic events, with the community prevalence rate for the combined populations reaching as high as 12%. If left untreated, PTSD may continue for years after the stressor event, resulting in severe functional and emotional impairment and a dramatic reduction in quality of life, with negative economic consequences for both the sufferer and society as a whole. Although PTSD is often overlooked, diagnosis is relatively straight-forward once a triggering stressor event and the triad of persistent symptoms—reexperiencing the traumatic event, avoiding stimuli associated with the trauma, and hyperarousal—have been identified. However, comorbid conditions of anxiety and depression frequently hamper accurate diagnosis. Treatment for PTSD includes psychotherapy and pharmacotherapy. The latter includes selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors. Only SSRls have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12–24 months.

Type
Academic Supplement
Information
CNS Spectrums , Volume 8 , supplement S1: Recommendations for the Long-Term Treatment of Anxiety Disorders , August 2003 , pp. 31 - 39
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.Google Scholar
2.Kessler, RC, Sonnega, A, Bromet, E, Hughes, M, Nelson, CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–1060.CrossRefGoogle ScholarPubMed
3.Breslau, N, Kessler, RC, Chilcoat, HD, Schultz, LR, Davis, GC, Andreski, P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55:626–632.CrossRefGoogle ScholarPubMed
4.Breslau, N, Davis, GC, Andreski, P, Peterson, E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 1991;48:216–222.CrossRefGoogle Scholar
5.Breslau, N, Davis, GC, Andreski, P, Peterson, EL, Schultz, LR. Sex differences in posttraumatic stress disorder. Arch Gen Psychiatry. 1997;54:1044–1048.CrossRefGoogle ScholarPubMed
6.Brewin, CR, Andrews, B, Valentine, JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748–766.CrossRefGoogle ScholarPubMed
7.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
8.Yehuda, R. Linking the neuroendocrinology of post-traumatic stress disorder with recent neuroanatomic findings. Semin Clin Neuropsychiatry. 1999;4:256–265.Google ScholarPubMed
9.Post-traumatic Stress Disorder: Diagnosis, Management and Treatment. Nutt, DJ, Davidson, J, Zohar, J, eds. London, England: Martin Dunitz Publishers; 2000.CrossRefGoogle Scholar
10.Nutt, DJ. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 2000;61:24–32.Google ScholarPubMed
11.Yehuda, R. Post-traumatic stress disorder. N Engl J Med. 2002;346:108–114.CrossRefGoogle ScholarPubMed
12.Pitman, RK, Shin, LM, Rauch, SL. Investigating the pathogenesis of post-traumatic stress disorder with neuroimaging. J Clin Psychiatry. 2001;62(suppl 17):47–54.Google ScholarPubMed
13.Pitman, RK, Shin, LM, Rauch, SL. Investigating the pathogenesis of post-traumatic stress disorders with neuroimaging. J Clin Psychiatry. 2001;62(suppl 17):47–54.Google ScholarPubMed
14.Hamner, MB, Lorberbaum, JP, George, MS. Potential role of the anterior cingulate cortex in PTSD: review and hypothesis. Depress Anxiety. 1999;9:1–14.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
15.Pitman, RK. Overview of biological themes in PTSD. Ann NY Acad Sci. 1997;821:1–9.CrossRefGoogle ScholarPubMed
16.Southwick, SM, Paige, S, Morgan, CA 3rd, Bremner, JD, Krystal, JH, Charney, DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry. 1999;4:242–248.Google ScholarPubMed
17.Southwick, SM, Bremner, JD, Rasmusson, A, Morgan, CA 3rd, Arnsten, A, Charney, DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;46:1192–1204.CrossRefGoogle ScholarPubMed
18.Warshaw, MG, Fierman, E, Pratt, L, et al.Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD. Am J Psychiatry. 1993;150:1512–1516.Google ScholarPubMed
19.Brady, KT. Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. J Clin Psychiatry. 1997;58(suppl 9):12–15.Google ScholarPubMed
20.Solomon, SD, Davidson, JR. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry. 1997;58(suppl 9):5–11.Google ScholarPubMed
21.Friedman, MJ. PTSD diagnosis and treatment for mental health clinicians. Community Ment Health J. 1996;32:173–189.CrossRefGoogle ScholarPubMed
22.Zatzick, DF, Marmar, CR, Weiss, DS, et al.Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans. Am J Psychiatry. 1997;154:1690–1695.CrossRefGoogle Scholar
23.Ballenger, JC, Davidson, JR, Lecrubier, Y, et al.Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2000;61(suppl 5):60–66.Google Scholar
24.Kessler, RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000;61(suppl 5):4–12.Google Scholar
25.Greenberg, PE, Sisitsky, T, Kessler, RC, et al.The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435.CrossRefGoogle ScholarPubMed
26.The International Classification of Diseases. 10th revision. Geneva, Switzerland: World Health Organization; 1992.Google Scholar
27.Peters, L, Slade, T, Andrews, G. A comparison of 1CD-10 and DSM-IV criteria for posttraumatic stress disorder. J Trauma Stress. 1999;12:335–343.CrossRefGoogle Scholar
28.Blake, DD, Weathers, FW, Nagy, LM, et al.The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8:75–90.Google ScholarPubMed
29.Guy, W. Clinical Global Impressions. NCDEU Assessment Manual. Psychopharmacohgy. 1916;217–222.Google Scholar
30.Weiss, D, Marmar, C. The Impact of Event Scale-Revised. In: Wilson, J, Keane, T, eds. Assessing Psychological Trauma and PTSD. New York, NY: Guildford; 1997.Google Scholar
31.Davidson, JR, Book, SW, Colket, JT, et al.Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997;27:153–160.CrossRefGoogle ScholarPubMed
32.Davidson, JR, Colket, JT. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol. 1997;12:41–45.CrossRefGoogle Scholar
33.Keane, TM, Caddell, JM, Taylor, KL. Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity. J Consult Clin Psychol. 1988;56:85–90.CrossRefGoogle ScholarPubMed
34.Sloan, P, Arsenault, L, Hilsenroth, M, Harvill, L. Use of the Mississippi scale for combat-related PTSD in detecting war-related, non-combat stress symptomatology. J Clin Psychol. 1995;51:799–801.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
35.The Expert Consensus Guideline Series. Treatment of posttraumatic stress disorder. The Expert Consensus Panels for PTSD. J Clin Psychiatry. 1999;60(suppl 16):3–76.Google Scholar
36.Foa, EB, Keane, TM, Friedman, MJ. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. New York, NY: Guildford Press; 2000.Google Scholar
37.Davidson, J, Kudler, H, Smith, R, et al.Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47:259–266CrossRefGoogle ScholarPubMed
38.Stein, DJ, Zungu-Dirwayi, N, van Der, Linden GJ, Seedat, S. Pharmacotherapy for posttraumatic stress disorder. Cochrane Database Syst Rev. 2000;CD002795.CrossRefGoogle ScholarPubMed
39.Davidson, JRT, Connor, KM. Management of posttraumatic stress disorder: diagnostic and therapeutic issues. J Clin Psychiatry. 1999;60(suppl 18):33–38.Google ScholarPubMed
40.van der, Kolk BA, Dreyfuss, D, Michaels, M, et al.Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55:517–522.Google Scholar
41.Zohar, J. Double-blind, placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2001;22:190–195.CrossRefGoogle Scholar
42.Davidson, JR, Rothbaum, BO, van der Kolk, BA, Sikes, CR, Farfel, GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485–492.CrossRefGoogle ScholarPubMed
43.Brady, K, Pearlstein, T, Asnis, GM, et al.Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837–1844.CrossRefGoogle ScholarPubMed
44.Rothbaum, BO, Ninan, PT, Thomas, L. Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress. 1996;9:865–871.CrossRefGoogle ScholarPubMed
45.Brady, KT, Sonne, SC, Roberts, JM. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry. 1995;56:502–505.Google ScholarPubMed
46.Connor, KM, Sutherland, SM, Tupler, LA, Malik, ML, Davidson, JR. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br J Psychiatry. 1999;175:17–22.CrossRefGoogle ScholarPubMed
47.Martenyi, F, Brown, E, Zhang, H, Prakash, A, Koke, S. Fluoxetine versus placebo in posttraumatic stress disorder. Poster presented at: 154th Annual Meeting of the American Psychiatric Association; New Orleans, La; May 5–10, 2001.CrossRefGoogle Scholar
48.Marshall, RD, Beebe, KL, Oldham, M, Zaninelli, R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982–1988.CrossRefGoogle ScholarPubMed
49.Ruggiero, L, Pitts, CD, Dillingham, K, Zaninelli, R. A flexible-dose study of paroxetine in the treatment of PTSD. Poster presented at: 154th Annual Meeting of the American Psychiatric Association; May 5–10, 2001; New Orleans, La.Google Scholar
50.Kosten, TR, Frank, JB, Dan, E, McDougle, CJ, Giller, EL Jr.Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nero Mem Dis. 1991; 179:366–370.CrossRefGoogle ScholarPubMed
51.Baker, DG, Diamond, BI, Gillette, G, et al.A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995;122:386–389.CrossRefGoogle ScholarPubMed
52.Davidson, JR. Biological therapies for posttraumatic stress disorder: an overview. J Clin Psychiatry. 1997;58(suppl 9):29–32.Google ScholarPubMed
53.Katz, RJ, Lott, MH, Arbus, P, et al.Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1:169–174.CrossRefGoogle ScholarPubMed
54.Gelpin, E, Bonne, O, Peri, T, Brandes, D, Shalev, AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57:390–394.Google ScholarPubMed
55.Viola, J, Ditzler, T, Batzer, W, et al.Pharmacological management of post-traumatic stress disorder: clinical summary of a five-year retrospective study, 1990–1995. Mil Med. 1997;162:616–619.CrossRefGoogle ScholarPubMed
56.Risse, SC, Whitters, A, Burke, J, Chen, S, Scurfield, RM, Raskind, MA. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. J Clin Psychiatry 1990;51:206–209.Google ScholarPubMed
57.Yehuda, R. Managing anger and aggression in patients with posttraumatic stress disorder. J Clin Psychiatry. 1999;60(suppl 15):33–37.Google ScholarPubMed
58.Hertzberg, MA, Butterfield, MI, Feldman, ME, et al.A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry. 1999,45:1226–1229.CrossRefGoogle ScholarPubMed
59.Londborg, PD, Hegel, MT, Goldstein, S, et al.Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Ciin Psychiatry. 2001;62:325–331.Google ScholarPubMed
60.Davidson, JR, Londborg, P, Pearlstein, T, Rothbaum, B, Brady, K, Farfel, G. Sertraline and post-traumatic stress disorder: results of 24 weeks of open-label treatment followed by a 28-week discontinuation study. Poster presented at: XIII Congress of the European College of Neuropsychopharmacology; September 9–13, 2000; Munich, Germany.Google Scholar
61.Davidson, J, Pearlstein, T, Londborg, P, et al.Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry. 2001;158:1974–1981.CrossRefGoogle ScholarPubMed
62.Rapaport, M, Endicott, J, Clary, C. Quality of life in long-term sertraline treatment for PTSD. Poster presented at: 7th World Congress of Biological Psychiatry; July 1–6, 2001; Berlin, Germany.Google Scholar
63.Foa, EB, Meadows, EA. Psychosocial treatments for posttraumatic stress disorder: a critical review. Annu Rev Psychol. 1997;48:449–480.CrossRefGoogle ScholarPubMed
64.Keane, TM, Fairbank, JA, Caddell, JM. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989;20:245–260.CrossRefGoogle Scholar
65.Foa, EB, Dancu, CV, Hembree, EA, Jaycox, LH, Meadows, EA, Street, GP. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Ciin Psychol. 1999;67:194–200.CrossRefGoogle ScholarPubMed
66.Marks, I, Lovell, K, Noshirvani, H, Livanou, M, Thrasher, S. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998,55:317–325.CrossRefGoogle ScholarPubMed